KRM-III is an orally active T cell antigen receptor (TCR) inhibitor with anti-inflammatory activity that potently inhibits TCR and myristate acetate/fosfomycin/ionomycin-induced NFAT nuclear factor activation and T cell proliferation, with an IC50 of approximately 5 µM.
Molekulargewicht:
252.33
Reinheit:
99.97%
CAS Nummer:
[79220-94-3]
Formel:
C15H12N2S
Target-Kategorie:
Others
T35885
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten